Medscape5d
Activated Partial Thromboplastin Time versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
The most prevalent reasons for exclusion included heparin infusion for less than 24 ... Xa HA group and 9 of 32 patients excluded from the aPTT group. The sample included a high proportion of ...
Medscape1d
Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Patients With Cirrhosis and Associated Coagulopathies
With regard to potential clinical markers of VTE risk in the context of cirrhosis, data from two studies suggested that serum albumin might serve as a reliable marker of coagulation status and ...
BMJ6d
Left ventricular thrombus formation after acute myocardial infarction
It could be postulated that factors involved in the coagulation cascade could serve as biomarkers ... thrombus formation in patients who received either thrombolytic therapy or heparin.5 Intravenous ...
Too Old to Operate1d
Outcomes of Rigid Bronchoscopy-Guided PDT in High-Risk Cases
The following is a summary of “Safety and Efficacy of Rigid Bronchoscopy-guided Percutaneous Dilational Tracheostomy,” ...
BMJ6d
Advancing clinical management of left ventricular thrombosis: prevention, detection and treatment modalities in the modern era
Previous studies have identified several potential predisposing factors, including ventricular aneurysm, low LVEF, and alterations in coagulation and inflammatory markers. The relative weight of these ...